Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions

J Harsfalvi, JM Stassen, MF Hoylaerts, E Van Houtte, RT Sawyer, J Vermylen, H Deckmyn

Blood (1995) 85 (3): 705–711.

https://doi.org/10.1182/blood.V85.3.705.bloodjournal853705

Published: 1995

Journal Articles

Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters

H Deckmyn, JM Stassen, I Vreys, E Van Houtte, RT Sawyer, J Vermylen

Blood (1995) 85 (3): 712–719.

https://doi.org/10.1182/blood.V85.3.712.bloodjournal853712

Published: 1995

Journal Articles

Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin- specific antibody fused to single-chain urokinase

P Holvoet, Y Laroche, JM Stassen, HR Lijnen, B Van Hoef, F De Cock, A Van Houtven, Y Gansemans, G Matthyssens, D Collen

Blood (1993) 81 (3): 696–703.

https://doi.org/10.1182/blood.V81.3.696.696

Published: 1993

Journal Articles

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg- Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model

Y Imura, JM Stassen, S Bunting, F Stockmans, D Collen

Blood (1992) 80 (5): 1247–1253.

https://doi.org/10.1182/blood.V80.5.1247.1247

Published: 1992

Journal Articles

Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboons

Y Imura, JM Stassen, T Kurokawa, S Iwasa, HR Lijnen, D Collen

Blood (1992) 79 (9): 2322–2329.

https://doi.org/10.1182/blood.V79.9.2322.2322

Published: 1992

Journal Articles

Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1

XK Li, HR Lijnen, L Nelles, B Van Hoef, JM Stassen, D Collen

Blood (1992) 79 (2): 417–429.

https://doi.org/10.1182/blood.V79.2.417.417

Published: 1992

Journal Articles

Effect of chemical conjugation of recombinant single-chain urokinase- type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo

M Dewerchin, HR Lijnen, JM Stassen, F De Cock, T Quertermous, MH Ginsberg, EF Plow, D Collen

Blood (1991) 78 (4): 1005–1018.

https://doi.org/10.1182/blood.V78.4.1005.1005

Published: 1991

Journal Articles

Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model

HR Lu, HR Lijnen, JM Stassen, D Collen

Blood (1991) 78 (1): 125–131.

https://doi.org/10.1182/blood.V78.1.125.125

Published: 1991

Journal Articles

Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits

DJ Spriggs, JM Stassen, Y Hashimoto, D Collen

Blood (1989) 73 (5): 1207–1212.

https://doi.org/10.1182/blood.V73.5.1207.1207

Published: 1989

Journal Articles

Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits

D Collen, JM Stassen, G Larsen

Blood (1988) 71 (1): 216–219.

https://doi.org/10.1182/blood.V71.1.216.216

Published: 1988

Journal Articles

Comparative thrombolytic properties of single-chain forms of urokinase- type plasminogen activator

DC Stump, JM Stassen, E Demarsin, D Collen

Blood (1987) 69 (2): 592–596.

https://doi.org/10.1182/blood.V69.2.592.592

Published: 1987

Journal Articles

Influence of fibrin and liver blood flow on the turnover and the systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator in rabbits

H Bounameaux, JM Stassen, C Seghers, D Collen

Blood (1986) 67 (5): 1493–1497.

https://doi.org/10.1182/blood.V67.5.1493.1493

Published: 1986

NARROW

Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions

Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters

Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin- specific antibody fused to single-chain urokinase

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg- Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model

Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboons

Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1

Effect of chemical conjugation of recombinant single-chain urokinase- type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo

Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model

Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits

Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits

Comparative thrombolytic properties of single-chain forms of urokinase- type plasminogen activator

Influence of fibrin and liver blood flow on the turnover and the systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator in rabbits

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only